Radiopharmaceuticals Market

Radiopharmaceuticals use in Diagnostic and
Therapeutic Application by - 2024
[DATE]
[COMPANY NAME]
[Company address]
Report Description
Radiopharmaceuticals Market Overview
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in
clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and
storage of radiopharmaceuticals are subject to license approval either by national or regional authorities
such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or
Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding
pharmaceutical preparations and use of radioactive materials.
Ask for FREE SAMPLE REPORT @ https://www.coherentmarketinsights.com/insight/requestsample/70
A radiopharmaceutical preparation is a medicinal product in a ready-to-use format containing a
radionuclide suitable for human use. A kit for radiopharmaceutical preparation encloses a vial containing
the non-radionuclide components of a radiopharmaceutical preparation in a sterilized and validated form,
to which the appropriate radionuclide is added. Radiopharmaceuticals derived from the kits are intended
to be used within 12 hours of preparation.
Technetium-99m – Widely used Radioisotope in Diagnostic Procedures fueling growth of the
radiopharmaceuticals market
There are over 40 radioisotopes available for use in different therapies. Technetium-99m is the most
widely used radioisotope in the diagnostic procedures. Technetium-99m is used as a radioactive tracer,
and can be detected in the body by medical equipment (gamma cameras). It is well suited to the role, as
it emits readily detectable gamma rays with photon energy of 140 keV. According to International Atomic
Energy Agency, over 80% of the total nuclear diagnostic procedures performed worldwide use
Technetium-99 as a radiotracer each year and hence, propels the radiopharmaceuticals market growth.
Radiopharmaceuticals use in Diagnostic and Therapeutic Application fuels growth of the
radiopharmaceuticals market
The chemical and physical identity is of vital importance, as during administration it targets certain tissues,
binding sites, and biochemical pathways. The radiopharmaceuticals market is divided into two major
areas, namely, diagnostic and therapeutic. Therapeutic applications of radiopharmaceuticals market
include cardiology (myocardial perfusion), oncology (tumor imaging and localization), and neurology
(cerebral perfusion). Radiopharmaceuticals such as iodine-131 or iodine-125 labeled m-iodobenzyl
guanidine (MIGB) are used to treat pheochromocytoma and neuroblastoma. The therapeutic segment
radiopharmaceuticals market can be further sub-segmented on the basis of procedure into beta emitters,
alpha emitters, and brachytherapy.
The diagnostic segment of radiopharmaceuticals market is classified into SPECT and PET. Single photon
emission computed tomography (SPECT) adoption has grown steadily over the last decade and is used
in the study of cerebral blood flow imaging. Positron emission tomography (PET) is a functional imaging
technique used to observe metabolic processes in the body. System detects pairs of gamma rays emitted
by a positron emitting radionuclide. SPECT radioisotopes are used for diagnosis of diseases such as
cancer, cardiovascular diseases, and thyroid and neurological disorders.
Radiopharmaceuticals – Used in Hospitals for Diagnosis
End users of radiopharmaceuticals include hospitals, research institutes, and diagnostic labs. These can
be used in hospitals for diagnosis and detection of various diseases such as bone-related pathology, bone
pain, stress fracture, bone infections, and spread of cancer in the bone. They are also used in detection
and scanning such as in neurology and cardiology.
Application of Radiopharmaceuticals across the Globe
Radiopharmaceuticals are widely used in North America, mainly due to availability of advanced healthcare
infrastructure, technological advancements, superior medical facilities, and supportive government
support. These are also widely used in Europe due to new procedures for diagnosis of diseases and
robust medical infrastructure in the region. Radiopharmaceuticals market is projected to witness rampant
growth in Asia due to rapid rise in research work in the sector and rising public awareness.
Key players involved in radiopharmaceuticals market
The market is fragmented, with the presence of various major players such as Kimberly-Clark Corporation,
Eli Lilly and Company, Lantheus Medical Imaging Inc., Ampio Pharmaceuticals Inc., GE Healthcare,
Piramal Imaging, Covidien Plc., Cardinal Health, Iso Tex Diagnostics, Inc., Jubilant DraxImage Inc., Bayer
HealthCare Pharmaceuticals Inc., Bracco Diagnostic Inc., Navidea Biopharmaceuticals, Nordion Inc.,
Spectrum Pharmaceuticals, Inc., Mallinckrodt Plc., Bio-Nucleonics Inc., and IBA-Molecular.
Get More Details About This Report @ https://www.coherentmarketinsights.com/ongoinginsight/radiopharmaceuticals-market-70
Conclusion
Growth of the radiopharmaceuticals market is projected to witness rapid traction in the near future due to
its high potential in diagnosis and detection of diseases related to cardiology, neurology, and oncology.
Developed regions are expected to be highly lucrative markets for this technology, due to the high capital
investment involved and availability of advanced medical facilities in these regions. Major players in the
global Positron Emission Tomography (PET) scanners market are concentrating on enhancing their global
and regional presence through strategic operational expansion and collaborations with regional players.
About Us
COMPANY OVERVIEW
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting
our plethora of clients achieve transformational growth by helping them make critical business decisions.
We are headquartered in India, having office at global financial capital in the U.S. Our client base includes
players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to
help businesses around the globe deliver practical and lasting results through various recommendations
about operational improvements, technologies, emerging market trends and new working methods. We
offer both customized and syndicated market research reports that help our clients create visionary growth
plans to provide traction to their business. We meticulously study emerging trends across various
industries at both the global and regional levels to identify new opportunities for our clientele. Our global
team of over 100 research analysts and freelance consultants provide market intelligence from the very
molecular country level and also provide a global perspective of the market. Our team is of the most vital
cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive
defusion training module.This allows for an objective and unbiased assessment of the market. We pride
ourselves in my constantly striving to update our extremely in-depth understanding of the market by
closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable
industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize
on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth
path in the future.
Contact Us
CONTACT US
CORPORATE OFFICE:
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com